MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-UP-01-0010234
Wyatt Pharma Private Limited
Wyatt Pharma Private Limited - trading in Agra, Uttar Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹14.82 Lakh
▲ 36% YoY
Net profit · FY 2025
₹6,157
Net margin 0.4%
EBITDA · FY 2025
₹9,947
EBITDA margin 0.7%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
7 yrs
Est. 2019
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Wyatt Pharma Private Limited
Data last updated:
Wyatt Pharma Private Limited is a private limited company based in Agra, Uttar Pradesh, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 03 January 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U51909UP2019PTC111879. Its GSTIN is 09AACCW3448B1ZG (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Hemlata Singhal and Aaditya Vishal Singhal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 12 Rahul Vihar Dayal Bagh, Agra, Uttar Pradesh, India – 282005.
As per the financials filed for FY 2025, the company reported a revenue of ₹14.82 Lakh, a growth of 36% compared to the previous year. For the same year it recorded a net profit of ₹6,157 (net margin 0.4%) and EBITDA of ₹9,947 (EBITDA margin 0.7%). Revenue has grown at a compounded annual rate (CAGR) of 93% over five years.
Wyatt Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-01-0010234). The current compliance status is marked as compliant by the Registrar of Companies.
Company Details of Wyatt Pharma Private Limited
CIN U51909UP2019PTC111879
Registration Number 111879
Incorporation Date 03 January 2019
ROC Kanpur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-UP-01-0010234
Recognitions & Rankings of Wyatt Pharma
Contact Details
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address12 Rahul Vihar Dayal Bagh, Agra, Uttar Pradesh, India – 282005
- IndustryTrading, Specialty, Wholesale
Comprehensive company report
Wyatt Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Wyatt Pharma Private Limited
The main business activity of Wyatt Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Wyatt Pharma Private Limited FY 2025 filings available
Wyatt Pharma Private Limited reported revenue of ₹14.82 Lakh (up 36% YoY) for FY 2025.
Revenue · FY 2025
₹14.82 Lakh ▲ 36%
Net profit · FY 2025
₹6,157 margin 0.4%
EBITDA · FY 2025
₹9,947 margin 0.7%
Compounded Annual Growth Rate (CAGR) of Wyatt Pharma Private Limited
Revenue CAGR growth
1 year
▲ 36%
5 years · compounded
▲ 93%
EBITDA CAGR growth
1 year
▼ 23%
3 years · compounded
▲ 36%
5 years · compounded
▲ 16%
Revenue has grown at a compounded annual rate (CAGR) of 93% over five years, including 36% growth in the latest year. EBITDA fell 23% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Wyatt Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹9,947 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹6,157 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Wyatt Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Wyatt Pharma are in the company report.
Premium access
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Wyatt Pharma Private Limited
Wyatt Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Hemlata Singhal | Director | 03 Jan 2019 | 7 Years 9 Months | Current |
| Aaditya Vishal Singhal | Director | 06 Aug 2022 | 4 Years 2 Months | Current |
Peer Comparison of Wyatt Pharma Private Limited
Wyatt Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Wholesale Trading). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Pramilja Medicos Private Limited | ₹14.83 Lakh (FY 2025) | •••• | •••• | 27.0% | •••• | Ghaziabad, Uttar Pradesh, India |
| Oriental Dealers Private Limited | ₹14.83 Lakh (FY 2025) | •••• | •••• | -3.0% | •••• | Kolkata, West Bengal, India |
| Seaborne Steel Resources Private Limited | ₹14.82 Lakh (FY 2025) | •••• | •••• | -41.0% | •••• | Gurugram, Haryana, India |
| Liberson Trading Private Limited | ₹14.82 Lakh (FY 2018) | •••• | •••• | -99.0% | •••• | Howrah, West Bengal, India |
| Hari-Milan Apparels (OPC) Private Limited | ₹14.82 Lakh (FY 2024) | •••• | •••• | -68.0% | •••• | Ahmedabad, Gujarat, India |
| Wyatt Pharma Private Limited this company | ₹14.82 Lakh (FY 2025) | •••• | •••• | 36.0% | •••• | Agra, Uttar Pradesh, India |
| Vaijnath Suppliers and Inspection Services Private Limited | ₹14.82 Lakh (FY 2021) | •••• | •••• | 137.0% | •••• | Dist-Mahesana, Gujarat, India |
| Ambient Lifesciences Private Limited | ₹14.82 Lakh (FY 2025) | •••• | •••• | 34155.0% | •••• | Dehradun, Uttarakhand, India |
| Ips Healthcare Solutions Private Limited | ₹14.82 Lakh (FY 2025) | •••• | •••• | 9.0% | •••• | Mohali, Punjab, India |
| Wemech Innovation Private Limited | ₹14.82 Lakh (FY 2022) | •••• | •••• | -25.0% | •••• | Indore, Madhya Pradesh, India |
| Ya Habeeb Impex Private Limited | ₹14.82 Lakh (FY 2025) | •••• | •••• | 193.0% | •••• | Chennai, Tamil Nadu, India |
Peers are the five companies nearest above and the five nearest below Wyatt Pharma by revenue in the same principal business activity (Wholesale Trading), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Ownership and Shareholding of Wyatt Pharma Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Wyatt Pharma Private Limited
Wyatt Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Wyatt Pharma Private Limited
Employment history and EPFO contributions of people linked to Wyatt Pharma.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Wyatt Pharma Private Limited
Wyatt Pharma Private Limited has 4 board changes on record since 2019: 2 appointments and 2 cessations. The latest: Aaditya Vishal Singhal ceased to be Additional Director on 30 Sep 2022.
AGM
Wyatt Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Wyatt Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kanpur.
Ceased
Aaditya Vishal Singhal ceased to be Additional Director.
Ceased
Vishal Singhal ceased to be Director.
Appointed
Aaditya Vishal Singhal was appointed as Director.
Appointed
Hemlata Singhal was appointed as Director.
Incorporation
03 Jan 2019
Wyatt Pharma Private Limited was registered on 03 Jan 2019 with Roc Kanpur & aged 7 years 9 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Wyatt Pharma Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Wyatt Pharma Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Wyatt Pharma Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Wyatt Pharma Private Limited
Wyatt Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AACCW3448B1ZG | Uttar Pradesh | Active | 25 Jan 2022 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Wyatt Pharma Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Wyatt Pharma Private Limited
Wyatt Pharma is an active private limited company based in Agra, Uttar Pradesh, India. The company works in specialty, within the trading industry. It was incorporated on 03 January 2019 (7+ years old) and is registered under CIN U51909UP2019PTC111879.
Wyatt Pharma reported revenue of ₹14.82 Lakh for FY 2025 (up 36% YoY).
Wyatt Pharma has 2 current directors:
- Hemlata Singhal - Director
- Aaditya Vishal Singhal - Director
Wyatt Pharma reported a net profit of ₹6,157 (net margin 0.4%) and EBITDA of ₹9,947 (EBITDA margin 0.7%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Wyatt Pharma is 93% over five years. In the latest year (FY 2025) revenue rose 36%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Wyatt Pharma is 09AACCW3448B1ZG, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Wyatt Pharma is U51909UP2019PTC111879. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Wyatt Pharma was incorporated on 03 January 2019, making it 7+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Wyatt Pharma by revenue are Pramilja Medicos Private Limited, Oriental Dealers Private Limited, Seaborne Steel Resources Private Limited, Liberson Trading Private Limited, Hari-Milan Apparels (OPC) Private Limited and 5 more, all in the same principal business activity (Wholesale Trading).
Aaditya Vishal Singhal ceased to be Additional Director on 30 Sep 2022. Vishal Singhal ceased to be Director on 08 Aug 2022. Aaditya Vishal Singhal was appointed as Director on 06 Aug 2022. Wyatt Pharma has 4 board changes on record in total.
Yes, Wyatt Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-01-0010234).